Research Programs

DEBRA Australia Ltd. also supports research activities aimed at improving the health and well being of children and adults with Epidermolysis Bullosa (EB), in any of DEBRA’s priority research areas. DEBRA Australia Ltd. offers two grants of up to AUD $30,000 each annually.

Projects may be laboratory based, a clinical study, or a combination. Development of therapies, including possible gene-therapies, cell-therapies, drug therapies or protein therapies;

  • Wound healing and skin cancer in EB;
  • Clinical research to improve management of EB.
  • Biology and genetics of all forms of EB, where it can be shown that this may help lead to new approaches to treat EB.

DEBRA’s Research Priorities are:

  • Development of therapies, including possible gene-therapies, cell-therapies, drug therapies or protein therapies;
  • Wound healing and skin cancer in EB;
  • Clinical research to improve management of EB.
  • Biology and genetics of all forms of EB, where it can be shown that this may help lead to new approaches to treat EB.

Lastly, our research program also supports young researchers travelling to EB conferences where they can promote their research, gather latest research knowledge and form collaborations with national and international experts in EB.